PRECIPIO INC (PRPO)

Company Profile

Precipio Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Omaha, Nebraska and currently employs 53 full-time employees. The company went IPO on 2000-07-18. Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The company develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its technology enables testing to be completed in one rapid scanning process. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.

Company Info

PRECIPIO INC

12325 Emmet St

Omaha NEBRASKA 06511

P: 12037877888

CEO: Ilan Danieli

Employees: 53

Website: http://www.precipiodx.com/